These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9005716)

  • 1. [Oromandibular dystonia and botulinum toxins].
    Van Durme B; Loeb I; Van Reck J
    Acta Stomatol Belg; 1996 Mar; 93(1):37-41. PubMed ID: 9005716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of botulinum toxin in Meige's disease.
    Maurri S; Brogelli S; Alfieri G; Barontini F
    Riv Neurol; 1988; 58(6):245-8. PubMed ID: 3247565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.
    Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC
    Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum A toxin treatment for blepharospasm and Meige syndrome: report of 100 patients.
    Poungvarin N; Devahastin V; Chaisevikul R; Prayoonwiwat N; Viriyavejakul A
    J Med Assoc Thai; 1997 Jan; 80(1):1-8. PubMed ID: 9078810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of jaw-closing and jaw-opening idiopathic oromandibular dystonia.
    Singer C; Papapetropoulos S
    Parkinsonism Relat Disord; 2006 Mar; 12(2):115-8. PubMed ID: 16271495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of onabotulinum toxin type A injections in patients with Meige's syndrome.
    Duarte A; Coutinho L; Germiniani FMB; Teive HAG
    Arq Neuropsiquiatr; 2024 Apr; 82(4):1-7. PubMed ID: 38641339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam in Meige's syndrome.
    Yardimci N; Karatas M; Kilinc M; Benli S
    Acta Neurol Scand; 2006 Jul; 114(1):63-6. PubMed ID: 16774630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meige syndrome: a rare form of cranial dystonia that was treated successfully with botulinum toxin.
    Sabesan T
    Br J Oral Maxillofac Surg; 2008 Oct; 46(7):588-90. PubMed ID: 18346825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oromandibular dystonia.
    Lee KH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Oct; 104(4):491-6. PubMed ID: 17689275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Laryngeal dystonia--personal experience with botulin toxin treatment].
    Domzał TM; Tomczykiewicz K
    Neurol Neurochir Pol; 2002; 36(1):173-9. PubMed ID: 12053608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, placebo-controlled, crossover clinical trial of super blue-green algae in patients with essential blepharospasm or Meige syndrome.
    Vitale S; Miller NR; Mejico LJ; Perry JD; Medura M; Freitag SK; Girkin C
    Am J Ophthalmol; 2004 Jul; 138(1):18-32. PubMed ID: 15234278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meige's syndrome: A cranial dystonia treated with bilateral pallidal deep brain stimulation.
    Markaki E; Kefalopoulou Z; Georgiopoulos M; Paschali A; Constantoyannis C
    Clin Neurol Neurosurg; 2010 May; 112(4):344-6. PubMed ID: 20061080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blepharospasm-oromandibular dystonia syndrome (Meige's syndrome): clinical aspects.
    Tolosa E; Martí MJ
    Adv Neurol; 1988; 49():73-84. PubMed ID: 3278555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin in Meige's syndrome: A video-based case series.
    Pandey S; Sharma S
    Neurol India; 2018; 66(1):71-76. PubMed ID: 29322963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smothering dystonia in a patient with oromandibular dystonia.
    Grill S
    Mov Disord; 2004 Nov; 19(11):1374-5. PubMed ID: 15389989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic pharmacology of blepharospasm with oromandibular dystonia (Meige's syndrome).
    Klawans HL; Tanner CM
    Adv Neurol; 1988; 49():443-50. PubMed ID: 3278551
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dystonia as the cause of pharyngolaryngeal motility disorders].
    Zwirner P; Dressler D
    HNO; 1995 Aug; 43(8):498-501. PubMed ID: 7558908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silent event-related fMRI reveals deficient motor and enhanced somatosensory activation in orofacial dystonia.
    Dresel C; Haslinger B; Castrop F; Wohlschlaeger AM; Ceballos-Baumann AO
    Brain; 2006 Jan; 129(Pt 1):36-46. PubMed ID: 16280353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substantial improvement in a Meige's syndrome patient with levetiracetam treatment.
    Zesiewicz TA; Louis ED; Sullivan KL; Menkin M; Dunne PB; Hauser RA
    Mov Disord; 2004 Dec; 19(12):1518-21. PubMed ID: 15390069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blepharospasm and cranial-cervical dystonia (Meige's syndrome): familial occurrence.
    Jankovic J; Nutt JG
    Adv Neurol; 1988; 49():117-23. PubMed ID: 3344632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.